Arthritis, rheumatoid Trials in Palm Harbor, United States
Conditions / Arthritis, rheumatoid / Palm Harbor, United States
Clinical trials for Arthritis, rheumatoid investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01606761 | A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) | COMPLETED | PHASE3 |
| NCT00299546 | A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s) | COMPLETED | PHASE3 |
| NCT01856309 | Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 | COMPLETED | PHASE3 |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT01604343 | A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D) | COMPLETED | PHASE3 |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT01004432 | Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) | COMPLETED | PHASE3 |
| NCT02019472 | A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00346216 | Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen | COMPLETED | PHASE4 |
| NCT00113308 | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis | COMPLETED | PHASE3 |